Skip to main content

AusPAR: BNT162b2 (mRNA)

Australian Public Assessment Report
AusPAR
Device/Product Name
Comirnaty
Active ingredients
BNT162b2 (mRNA)
AusPAR Date
Published
Submission Number
PM-2021-02187-1-2
Submission Type
Extension of indications
Decision
Approved for provisional registration

Help us improve the Therapeutic Goods Administration site